Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Akero Therapeutics Q2 EPS $(0.77) Up From $(0.83) YoY

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.77) per share. This is a 7.23 percent increase over losses of $(0.83) per share from the same period last year.
byBenzinga Newsdesk
August 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.77) per share. This is a 7.23 percent increase over losses of $(0.83) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts